We are live on !
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$444M
Turnover
22.52%
1-Year Est. Return
151.5%
This Fund
S&P 500
This Quarter Est. Return
+1.63%
1 Year Est. Return
+151.5%
3 Year Est. Return
+379.06%
5 Year Est. Return
+493.54%
10 Year Est. Return
–
AUM
$444M
AUM Growth
-$122M
(-21%)
Cap. Flow
-$34.9M
Cap. Flow % of AUM
Cap. Flow %
-7.85%
Top 10 Holdings %
Top 10 Hldgs %
56.11%
Holding
111
New
18
Increased
28
Reduced
31
Closed
7
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2.2
years
Top 20 Avg Time Held
Equity + Options
2.4
years
Avg Time Held Equity only
2.7
years
Top 10 Avg Time Held Equity only
2.5
years
Top 20 Avg Time Held Equity only
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$3.26M |
| 2 |
Savara
SVRA
|
+$3.15M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$1.87M |
| 4 |
AstraZeneca
AZN
|
+$1.54M |
| 5 |
InflaRx
IFRX
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$32.3M |
| 2 |
Helus Pharma Inc. Common Stock
HELP
|
+$4.52M |
| 3 |
Cisco
CSCO
|
+$2.99M |
| 4 |
argenx
ARGX
|
+$2.35M |
| 5 |
MarineMax
HZO
|
+$2.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 31.93% |
| 2 | Technology | 28.38% |
| 3 | Healthcare | 23.81% |
| 4 | Communication Services | 5.79% |
| 5 | Consumer Discretionary | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
CALL
Altimmune
ALT
$375M
| $106K | 0.02% |
37,000
| – | – |
2025 Q4
3 quarters
|
|
102
Ardelyx
ARDX
$759M
| $92.3K | 0.02% |
27,000
+5,000
| +23% | +$21.4K |
2025 Q2
5 quarters
|
|
103
EyePoint Inc
EYPT
$33.3M
| $67K | 0.02% |
+20,500
| New | +$180K |
2026 Q3
0 quarters
|
|
|
104
Altimmune
ALT
$375M
| $42K | 0.01% |
14,700
| – | – |
2025 Q4
3 quarters
|
|
105
CALL
Amazon
AMZN
$2.92T
| – | – |
-2,000
| Closed | -$477K | – |
|
|
106
PUT
Amazon
AMZN
$2.92T
| – | – |
-3,000
| Closed | -$715K | – |
|
107
PUT
Alphabet (Google) Class A
GOOGL
$3.53T
| – | – |
-2,000
| Closed | -$715K | – |
|
108
CALL
iShares Bitcoin Trust
IBIT
$58.9B
| – | – |
-9,500
| Closed | -$316K | – |
|
109
CALL
Microsoft
MSFT
$3.97T
| – | – |
-6,200
| Closed | -$2.31M | – |
|
110
CALL
Starbucks
SBUX
$125B
| – | – |
-10,000
| Closed | -$1.02M | – |
|
|
111
CALL
Sanofi
SNY
$116B
| – | – |
-10,000
| Closed | -$427K | – |
|
Similar funds
VM
DCF Advisers's Q3 2026 Portfolio in Review
As of Q3 2026, DCF Advisers held 111 positions worth $444M, down 21% from $566M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
DCF Advisers withdrew a net $34.9M in Q3 2026, closing 7 positions and reducing 31 holdings. Its largest reduction was Micron Technology, cutting an estimated $32.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DCF Advisers opened a new position in Sanofi worth $3.09M.
- DCF Advisers's largest Q3 2026 buy was Sanofi: 75,000 shares worth $3.09M.
- DCF Advisers added most to Savara in Q3 2026, an estimated $3.15M increase.
- DCF Advisers's biggest Q3 2026 reduction was Micron Technology, cutting an estimated $32.3M.
- DCF Advisers's ten largest holdings make up 56% of its $444M portfolio in Q3 2026.
- DCF Advisers opened 18 new positions and closed 7 in Q3 2026.
- DCF Advisers's portfolio value fell 21% quarter-over-quarter to $444M.
Based on DCF Advisers's 13F filing for Q3 2026, filed 4 Nov 2026.